The pros and cons of discontinuing disease-modifying therapies in multiple sclerosis.
John R. Corboy, MD
Advertisement
Articles by John R. Corboy, MD
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on NeurologyLive - Clinical Neurology News and Neurology Expert Insights
1
Advanced Therapy with Apomorphine Pump in Parkinson’s Disease
2
SKY-0515 Demonstrates Sustained Mutant Huntingtin Lowering in Latest Phase 1/2 Study Update
3
Atogepant Gains European Approval as Acute and Preventive Migraine Therapy
4
What Clinicians Need to Know About Emerging Stem Cell Therapies for Parkinson Disease
5